#Point-of-Care-POC-Blood-Diagnostics-Market

[meditech-insights]

Point-of-Care (POC) Blood Diagnostics Market Higher Growth Rate and Forecast 2021 - 2026

Point-of-care (POC) testing involves performing a diagnostic test outside of a laboratory, or near a patient and at the site where care or treatment is provided. POC testing gives precise and timely results, assisting in the diagnosis and treatment of acute infections and chronic disorders. Key tests/products within POC blood diagnostics market include equipment/assays/reagents for blood gas, blood glucose, cardiac markers, infectious diseases, coagulation, hematology, and immunoassays.

The Global Point-of-Care (POC) Blood Diagnostics Market is set to witness a growth rate of 6% in the next 5 years. Growing incidence of cardiovascular and infectious diseases, expanding geriatric population prone to target diseases, scientific advancements in POC blood diagnostics, and increase in funding from public and private organizations are some of the key factors driving the Global Point-of-Care (POC) Blood Diagnostics Market.

New product improvement in POC blood diagnostics to drive the Point-of-Care (POC) Blood Diagnostics Market demand

Constant advances in disease diagnostics have enabled to develop efficient POC devices and technologies such as real-time patient data management remotely, rapid result delivery, requirement of low volume of blood, and multiplexing capability, among others. Such advancements tend to provide competitive edge to manufacturers and therefore, major players are continuously focusing on investing in research activities for new product development and expanding their geographic reach to strengthen their positions in point-of-care (poc) blood diagnostics market.

Some of the technological advancements are listed below:

•In May 2022, EKF Diagnostics launched its EKF Link digital connectivity solution to manage POC analyzers and associated data securely on one centralized platform. This new connectivity solution can be interfaced to POC analyzers from all vendors enabling real-time remote data management

•In April 2021, DiaSorin launched LIAISON IQ, an immunodiagnostic POC reader and LIAISON Quick Detect COVID TrimericS Ab test in countries accepting CE mark. The LIAISON IQ POC reader detects IgG antibodies against SARS-CoV-2 Spike Protein from a fingerstick in 10 minutes

•In March 2021, EKF Diagnostics launched STAT-Site WB handheld analyzer, that delivers β-ketone and glucose measurements in seconds from whole blood. This analyzer is reagent-free and utilizes two different test strips for delivering results in 5 seconds for glucose and 10 seconds for β-ketones

•In June 2019, Abbott launched Afinion HbA1c Dx test, a POC diabetes blood test that provides results in three minutes. This FDA cleared test is available for use on the company’s Afinion 2 and AS100 analyzers

Explore Premium Report on Point-of-Care (POC) Blood Diagnostics Market @ https://meditechinsights.com/point-of-care-poc-blood-diagnostics-market/

Expertise trends in POC blood diagnostics to fuel market growth

Connected health technology: Healthcare practitioners (HCPs) understand the importance of integrating connected health and artificial intelligence (AI) in POC blood diagnostics to deliver real-time results. More POC testing solutions driven by digital technologies to reduce the workload are expected by HCPs. For instance, AI can pick-up blind spots that are sometimes not visible to human eye, further assisting HCPs in quickly sorting patient data and providing efficient patient care.

Multiplex testing offers numerous advantages

Point-of-Care (POC) Blood Diagnostics Market players continuously focus on improving their existing portfolio in terms of high quality such accuracy (specificity/sensitivity) and faster turn-around times as well as develop innovative technologies. Owing to the unmet needs within infectious disease diagnostics segment, many new companies are coming in and focusing on launching POC molecular multiplexing systems which is expected to trigger the growth of this segment. Major application areas for this disrupting technology are meningitis and septicaemia. Multiplex testing offers various benefits such as time optimization by detection of multiple pathogens, more convenient and comfortable sample collection for patients, and cost-effectiveness as compared to other tests, among others.

Competitive Landscape Analysis of Point-of-Care (POC) Blood Diagnostics Market

The global point-of-care (poc) blood diagnostics market is marked by the presence of key players such as Radiometer Medical ApS (Denmark); WerfenLife, S.A. (Spain); F. Hoffman-la Roche (Switzerland); Abbott Laboratories. (US); Nova Biomedical Corporation (US); and others.

For More Comprehensive Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com

[home-basedpoint]

In recent years, the landscape of healthcare delivery has undergone a profound transformation with the advent of home-based point of care (POC) solutions. These innovative technologies empower individuals to monitor their health conditions conveniently from the comfort of their homes, marking a paradigm shift in how healthcare services are accessed and delivered. As the demand for personalized and convenient healthcare solutions continues to rise, the home-based POC market has emerged as a promising frontier, offering significant opportunities for both patients and healthcare providers.

Home-based POC devices encompass a diverse range of medical technologies designed to enable rapid and accurate diagnostic testing, monitoring, and treatment outside traditional clinical settings. From glucose monitoring systems for diabetic patients to portable ultrasound devices for prenatal care, these tools empower individuals to take control of their health and manage chronic conditions effectively. The market for home-based POC solutions is witnessing rapid growth, driven by factors such as the aging population, increasing prevalence of chronic diseases, and advancements in technology.

One of the key drivers fueling the expansion of the home-based POC market is the growing preference for patient-centric care models. With an emphasis on preventive care and early intervention, healthcare providers are increasingly recognizing the importance of empowering patients to actively participate in managing their health. Home-based POC devices enable real-time monitoring of vital signs and biomarkers, allowing for timely interventions and adjustments to treatment plans. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with hospital readmissions and complications.

Moreover, the COVID-19 pandemic has accelerated the adoption of home-based POC solutions as healthcare systems seek alternatives to traditional in-person consultations. Telemedicine platforms combined with remote monitoring devices have become invaluable tools for delivering virtual care, ensuring continuity of medical services while minimizing the risk of exposure to infectious diseases. Patients can consult with healthcare providers remotely and transmit vital health data in real-time, facilitating timely diagnosis and treatment decisions

For a comprehensive analysis of the market drivers:-https://univdatos.com/report/home-based-point-of-care-market/

The home-based POC market is characterized by a diverse array of products catering to various medical specialties and conditions. For instance, blood glucose meters, insulin pumps, and continuous glucose monitoring systems are indispensable tools for diabetic patients, enabling them to monitor blood sugar levels and adjust insulin dosages as needed. Similarly, cardiac monitoring devices offer non-invasive means of tracking heart rhythm abnormalities, providing early warning signs of cardiovascular events.

In addition to chronic disease management, home-based POC solutions are also proving instrumental in enhancing maternal and fetal health outcomes. Portable fetal dopplers and home ultrasound devices enable expectant mothers to monitor the well-being of their unborn babies from the comfort of their homes, reducing the need for frequent clinic visits. These technologies empower women to take a proactive role in their prenatal care, fostering greater peace of mind and reassurance throughout the pregnancy journey.

 However, the widespread adoption of home-based POC devices is not without challenges. Data security and privacy concerns remain paramount, particularly given the sensitive nature of health information transmitted through these devices. Ensuring compliance with regulatory standards and safeguarding patient data against breaches and unauthorized access are critical priorities for stakeholders in the home-based POC market.

For a sample report, visit:- https://univdatos.com/get-a-free-sample-form-php/?product_id=4974 

Furthermore, disparities in access to technology and digital literacy pose barriers to adoption, particularly among underserved populations and elderly individuals. Addressing these disparities requires targeted interventions to improve digital health literacy and expand access to affordable POC devices among vulnerable communities.

In conclusion, the home-based point of care market represents a dynamic and rapidly evolving segment of the healthcare industry, offering transformative benefits for patients, providers, and healthcare systems alike. By leveraging the power of technology to bring healthcare services directly to the homes of individuals, these innovative solutions have the potential to revolutionize the way healthcare is delivered, enhancing convenience, efficiency, and patient outcomes in the process. As the market continues to expand and mature, collaboration among stakeholders will be essential to overcome challenges and unlock the full potential of home-based POC solutions in improving global health outcomes.

Home-based point of care acceptance moved the delivery of healthcare from an office to the patient’s home as it provides patient-centered care at their homes. Home-based point of care are used as an alternative way for organizing and delivering care that may better address the needs, values, and preferences of chronically ill, fragile, and physically or cognitively disabled patients who have difficulty in accessing office-based primary care or other models of care that require office visits. According to the Home Healthcare News in 2020, the Medical Advantage plans cover non-medical, in-home support, and services. The flourishing new opportunity for home-based point of care providers to participate in Medical Advantage, serves 34% of all Medicare beneficiaries, with 22 million total enrollees. This shows the interest of other medical organizations in the home-based point of care market. Also, Amazon in march 2021, reveals their national expansion plans of an in-home care platform called “Amazon Care” which will provide on-demand health care service at patient’s homes.

Moreover, increasing technological advancement like remote patient monitoring and telehealth in home-based point of care services is likely to be a factor for the tremendous growth of the market. Also, the healthcare cost curve and excessive health expenditure have been reduced due to home-based point of care services. As, the researchers at the “Cleveland Clinic” in the United States determined that the use of home-based point of care services following inpatient care decreased the number of follow-ups, and hospital readmissions, saving nearly USD 6,500 per patient over a year. Likewise, according to the Centers for Medicare & Medicaid Services (CMS) in 2020, estimates that the home health care in Medicare saves at least USD 378 million a year through diminished hospitalizations, based on the nine states participating in the Home Health Value-Based Purchasing (HHVBP). Value-based care arrangements link quality, outcomes, safety, and other measures directly to reimbursements. This demand for patient-centric healthcare services at homes, in return, increases the requirement for healthcare workers and agencies and is anticipated as a driving factor for the market growth.

Contact Us: UnivDatos Market Insights Email - contact@univdatos.com  Contact Number - +1 9782263411 Website -www.univdatos.com

[spookysaladchaos]

Global Top 5 Companies Accounted for 77% of total POC HbA1C Testing market (QYResearch, 2021)

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.

HbA1c is your average blood glucose (sugar) levels for the last two to three months.

The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels.

In this report, we mainly study the devices for POC HbA1C Testing without services.

According to the new market research report “Global POC HbA1C Testing  Market Report 2023-2029”, published by QYResearch, the global POC HbA1C Testing  market size is projected to reach USD 0.85 billion by 2029, at a CAGR of 7.8% during the forecast period.

Figure.   Global POC HbA1C Testing Market Size (US$ Million), 2018-2029

Figure.   Global POC HbA1C Testing Top 5 Players Ranking and Market Share（Based on data of 2021, Continually updated）

The global key manufacturers of POC HbA1C Testing  include Abbott, Siemens, Roche, Sinocare (PTS Diagnostics), Trinity Biotech, EKF Diagnostics, Bio-Rad, SD Biosensor, HUMAN Diagnostics, Erba Diagnostics, etc. In 2021, the global top five players had a share approximately 77.0% in terms of revenue.

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

For more information, please contact the following e-mail address:

Email: global@qyresearch.com

Website: https://www.qyresearch.com

[businessresearchreportss]

Analyzing the Procalcitonin Tests Market by Test Type, End User, and Region

Analyzing the procalcitonin tests market by test type, end user, and region provides valuable insights into the factors driving demand and the dynamics of this market.

Buy the Full Report for More Insights on the Procalcitonin Tests Market Forecast, Download a Free Sample Report

Here's an analysis of each category:

Test Type:a. Procalcitonin Assay Kits: Procalcitonin assay kits are used in clinical laboratories and healthcare facilities to measure procalcitonin levels in patient blood samples. These kits typically utilize immunoassay techniques such as enzyme-linked immunosorbent assay (ELISA) or chemiluminescent immunoassay (CLIA) to quantitatively detect procalcitonin levels. Assay kits may be available in various formats, including manual assays and automated assay systems.b. Point-of-Care (POC) Tests: Point-of-care procalcitonin tests are rapid diagnostic tests designed for use at the bedside or in outpatient settings. POC tests offer the advantages of fast turnaround times, enabling timely decision-making regarding antibiotic therapy in patients with suspected sepsis or bacterial infections. These tests are typically based on lateral flow immunoassay or other rapid immunoassay technologies.

End User:a. Hospitals and Clinics: Hospitals and clinics represent the largest end-user segment for procalcitonin tests, accounting for a significant portion of test volumes. Procalcitonin testing is commonly performed in hospital laboratories and clinical settings to aid in the diagnosis and management of sepsis, bacterial infections, and other inflammatory conditions. Hospitals may utilize both laboratory-based assays and point-of-care tests depending on their testing requirements and infrastructure.b. Diagnostic Laboratories: Independent diagnostic laboratories and reference laboratories also play a key role in the procalcitonin tests market. These laboratories offer testing services to healthcare providers, including hospitals, clinics, and physician offices, and may perform procalcitonin testing as part of routine clinical laboratory services or specialized infectious disease testing panels.c. Ambulatory Care Centers: Ambulatory care centers, including urgent care centers and outpatient clinics, may perform procalcitonin testing to aid in the diagnosis and management of infectious diseases in ambulatory patients. Point-of-care procalcitonin tests are particularly well-suited for use in ambulatory care settings due to their rapid turnaround times and ease of use.

Region:a. North America: North America is a significant market for procalcitonin tests, driven by factors such as the high prevalence of sepsis and bacterial infections, well-established healthcare infrastructure, and increasing adoption of advanced diagnostic technologies. The region is characterized by a strong presence of key market players, extensive research and development activities, and stringent regulatory standards governing diagnostic testing.b. Europe: Europe is another major market for procalcitonin tests, with countries such as Germany, France, and the United Kingdom leading in terms of market share. The region benefits from a robust healthcare system, growing awareness of sepsis management protocols, and favorable reimbursement policies for diagnostic testing. Increasing efforts to combat antimicrobial resistance also drive demand for procalcitonin testing in Europe.c. Asia-Pacific: The Asia-Pacific region represents a rapidly growing market for procalcitonin tests, fueled by factors such as the rising incidence of infectious diseases, expanding healthcare infrastructure, and increasing healthcare expenditure. Countries such as China, India, and Japan are witnessing significant market growth, driven by investments in healthcare modernization, improving access to diagnostic services, and growing awareness of sepsis management strategies.d. Latin America, Middle East, and Africa: These regions also contribute to the global procalcitonin tests market, albeit to a lesser extent compared to North America, Europe, and Asia-Pacific. Market growth in these regions is influenced by factors such as the burden of infectious diseases, healthcare infrastructure development, and efforts to enhance diagnostic capabilities in underserved areas.

Analyzing the procalcitonin tests market by test type, end user, and region enables stakeholders to identify key market segments, understand regional variations in demand, and formulate targeted strategies to address the needs of different market segments. Factors such as healthcare infrastructure, regulatory landscape, reimbursement policies, and disease epidemiology play a crucial role in shaping market dynamics and market growth opportunities across different regions.

[david843346]

Magnetic Beads Market Size by Research Nester Reveals the Market to Grow with a CAGR of ~11% During 2023-2036

Research Nester’s recent market research analysis on “Magnetic Beads Market: Global Demand Analysis & Opportunity Outlook 2036” delivers a detailed competitors analysis and a detailed overview of the global magnetic beads market in terms of market segmentation by product, type, application, end-user and by region.

Request Report Sample@

Rising Application in Molecular Biology Application to Promote Global Market Share of Magnetic Beads Market

The global magnetic beads market is estimated to grow majorly on account of the increased usage in medical applications, DNA & RNA extraction methods, bioassays, and life sciences applications. Other than this, rising incidences of tumors and cancer are also propelling the demand for magnetic beads, especially for leukemia. It has been estimated that in the United States, a total of 184,721 people were diagnosed with leukemia. The magnetic beads are considered to help separate the cells and remove cell tumors from the bone marrow and isolate the lymphoid cells from the blood film. On the back of this, the global magnetic beads market is projected to flourish in the forecasted period. Other than this, research related to the microbiomes has become prominent in recent years. The increase in investment in microbiological and genetic research over a prolonged period is projected to boost the demand for the product remarkably. The usage of these beads will accelerate more research-based investigations will be conducted throughout, to discover new therapeutic methods worldwide. Furthermore, the demand for magnetic beads market is projected to expand on the back of the rising production of healthcare products. The rise in the trend of POC which is the point of care in the laboratories as well as at the door of patients is projected to raise the usage of magnetic beads.

Some of the major growth factors and challenges that are associated with the growth of the global magnetic beads market are:

Growth Drivers:

Rising Research Spending is Augmenting the Demand

Increased Usage of Magnetic Beads in Medicated Wearables

Challenges:

Factors such as a decrease in magnetic force with the rise in distance, exorbitant price of magnetic beads, and less research in the development of magnetic beads are some of the major factors anticipated to hamper the global market size of the global magnetic beads market.

By application, the global magnetic beads market is segmented into cell separation & cell expansion, exosome analysis, protein sample prep and protein isolation, IVD assay development, and nucleic acid isolation. Out of these, the IVD assay development segment will rise the most during the forecast period and is projected to garner revenue of almost 50%.

By region, the Europe magnetic beads market is to generate the highest revenue by the end of 2036. The market is projected to flourish because of the rising demand for diagnostic and therapeutic solutions.

Access our detailed report at:

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

[marketsizereports]

Key Players in the POC Analyzers Market: A Company Spotlight

The Point-of-Care (POC) Analyzers Market is vibrant, with several key players contributing to the development and advancement of portable diagnostic solutions.

Buy the Full Report for Detailed Segments Insights into the POC Analyzers Market, Download a Free Report Sample

This company spotlight highlights some of the prominent players in this dynamic market:

Abbott Laboratories:

Abbott is a global healthcare company with a diverse portfolio, including a range of POC analyzers. Their offerings cover areas such as blood glucose monitoring, cardiac markers, infectious diseases, and molecular diagnostics. Abbott aims to provide rapid and accurate diagnostic solutions to improve patient outcomes.

Roche Diagnostics:

Roche Diagnostics, a division of the Swiss multinational Roche Group, is a leading player in the POC analyzers market. Their portfolio includes devices for testing blood gases, electrolytes, cardiac markers, and coagulation parameters. Roche focuses on delivering reliable and efficient solutions for decentralized testing.

Siemens Healthineers:

Siemens Healthineers is a global medical technology company known for its innovative diagnostic solutions. In the POC analyzers market, Siemens offers devices for testing blood gases, cardiac markers, and infectious diseases. Their emphasis on connectivity and data management contributes to streamlined healthcare workflows.

Danaher Corporation (Beckman Coulter):

Beckman Coulter, a subsidiary of Danaher Corporation, is a key player in the POC diagnostics space. Their POC analyzers cover a wide range of parameters, including chemistry, hematology, and immunoassays. Beckman Coulter focuses on delivering solutions that enhance clinical decision-making.

Sysmex Corporation:

Sysmex, a Japanese multinational corporation, is a prominent player in the global in-vitro diagnostics market. In the POC analyzers segment, Sysmex offers solutions for hematology testing, contributing to rapid and accurate blood analysis in various healthcare settings.

Quidel Corporation:

Quidel Corporation specializes in diagnostic testing solutions, including a range of POC analyzers. Their portfolio covers tests for infectious diseases, cardiac markers, and women's health. Quidel aims to provide rapid and accurate results to facilitate timely clinical decisions.

Nova Biomedical:

Nova Biomedical is a U.S.-based company known for its commitment to POC testing solutions. They offer analyzers for blood gas, electrolyte, and critical care testing. Nova Biomedical focuses on delivering high-performance POC analyzers for use in various healthcare settings.

Alere Inc. (Now part of Abbott):

Alere, acquired by Abbott, was a major player in POC diagnostics before the acquisition. Their portfolio included rapid tests and analyzers for infectious diseases, cardiac markers, and women's health. The integration with Abbott has strengthened the company's position in the POC market.

BioMérieux SA:

BioMérieux, a French multinational company, is a key player in the field of in-vitro diagnostics. In the POC analyzers market, BioMérieux focuses on solutions for infectious disease testing, including molecular diagnostics and immunoassays.

PTS Diagnostics:

PTS Diagnostics specializes in developing and manufacturing POC diagnostic products. Their portfolio includes analyzers for lipid panels, diabetes management, and cardiovascular risk assessment. PTS Diagnostics aims to provide cost-effective and user-friendly solutions for decentralized testing.

It's important to note that the POC analyzers market is dynamic, and the landscape may have evolved since my last knowledge update. Additionally, new players may have entered the market, and strategic partnerships or acquisitions may have occurred. For the latest information, it's advisable to refer to recent reports, company announcements, and industry publications.

[alicesara611]

Harnessing the Power of Technology: Portable Vascular Doppler Devices Revolutionize Vascular Imaging By 2023 to 2030

The portable vascular doppler market is expected to grow at a CAGR of 7.5% from 2023 to 2030, reaching a value of US$ 2.2 billion by 2030, The growth of this market is being driven by several factors, including the increasing prevalence of cardiovascular diseases, the growing demand for minimally invasive procedures, and the rising adoption of portable vascular doppler devices in home healthcare settings.

Portable vascular doppler devices are used to assess blood flow and circulation in the body. These devices are non-invasive and easy to use, making them a popular choice for both medical professionals and home healthcare users. The devices are available in a variety of sizes and configurations, and can be used to assess blood flow in a variety of locations, including the arms, legs, neck, and abdomen.

Get your Sample Report with Latest Market Information! https://absolutemarketresearch.com/Global-Portable-Vascular-Doppler-Market/1700/request-sample

The increasing prevalence of cardiovascular diseases, such as coronary artery disease (CAD), peripheral artery disease (PAD), and venous thromboembolism (VTE), is the primary factor driving growth of the portable vascular doppler market. These diseases are major causes of morbidity and mortality worldwide, and portable vascular dopplers are essential diagnostic tools for their early detection and management.

In addition, the rising adoption of minimally invasive procedures, such as endovascular therapies, is also contributing to the growth of the portable vascular doppler market. These procedures require real-time visualization of blood flow, which can be effectively provided by portable vascular dopplers.

Furthermore, the increasing demand for point-of-care (POC) testing is also driving the growth of the portable vascular doppler market. POC testing allows healthcare providers to make rapid diagnoses and treatment decisions, which can improve patient outcomes.

North America is the largest market for portable vascular dopplers, followed by Europe and Asia Pacific. The growth of the North American market is being driven by the high prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures. The European market is also growing steadily, due to the increasing demand for POC testing and the rising prevalence of cardiovascular diseases. The Asia Pacific market is the fastest growing market, due to the increasing economic development and the rising prevalence of cardiovascular diseases.

Market Drivers:

There are several factors driving the growth of the portable vascular doppler market, including:

Rising prevalence of PAD: PAD is a condition that affects over 200 million people worldwide. It is a major cause of cardiovascular disease and death. The increasing prevalence of PAD is driving the demand for portable vascular doppler devices, which can be used to diagnose and monitor PAD.

Growing aging population: The global aging population is expected to reach 2 billion by 2050. Older adults are more likely to develop PAD, which is driving the demand for portable vascular doppler devices.

Increasing demand for minimally invasive procedures: Minimally invasive procedures are becoming increasingly popular, as they are associated with fewer complications and shorter recovery times. Portable vascular doppler devices are often used in minimally invasive procedures, which is driving the demand for these devices.

Key Takeaways:

The Portable Vascular Doppler Market is expected to grow at a CAGR of 7.5% from 2023 to 2030, reaching a value of US$ 2.2 billion by 2030.

The market is driven by the increasing prevalence of vascular diseases, the growing aging population, and the rising demand for minimally invasive procedures.

North America is expected to be the largest market for portable vascular Dopplers, followed by Europe and Asia Pacific.

Regional Outlook:

North America is expected to hold the largest market share of the global portable vascular Doppler market, owing to the high prevalence of vascular diseases, the presence of leading market players, and the well-established healthcare infrastructure in the region.

Europe is expected to be the second-largest market for portable vascular Dopplers, driven by the increasing demand for minimally invasive procedures and the growing awareness of vascular diseases in the region.

Asia Pacific is expected to be the fastest-growing market for portable vascular Dopplers, owing to the rising prevalence of vascular diseases, the growing aging population, and the increasing adoption of minimally invasive procedures in the region.

Key Players:

GE Healthcare

Siemens Healthineers

Koninklijke Philips N.V.

Hitachi Ltd.

Esaote SpA

Samsung Medison Co., Ltd

Mindray Medical International Limited

Analogic Corporation

FUJIFILM Sonosite Inc.

Huntleigh Medical

Spengler Holtec Medical GmbH

doppler ultrasound systems

Bionano Genomics

VTI Medical Technology

Segmentation:

By Portability:

Handheld Doppler Ultrasound System

Trolley-based Doppler Ultrasound System

By Application:

Obstetrics and Gynecology

Radiology

Cardiology

Others

By End User:

Hospitals

Clinics

Diagnostic Centers

Others

[report-1]

MarketPoint of Care POC Devices Market Growth, Trend, and Prospects from 2023–2030

Point of Care POC Devices Market Growth,

The Point of Care POC Devices Market is expected to grow from USD 1.70 Billion in 2022 to USD 3.10 Billion by 2030, at a CAGR of 7.80% during the forecast period.

Get the Sample Report:https://www.reportprime.com/enquiry/sample-report/10621

Point of Care POC Devices Market Size

Point of Care (POC) devices are portable diagnostic tools designed to provide rapid and accurate test results at the patient’s bedside. These devices are applicable for diagnosing various medical conditions such as blood glucose diagnostic, infectious diseases diagnostic, pregnancy diagnostic, urinalysis diagnostic, and others. The market for POC devices is segmented based on type, application, and region. The major players in this market include Roche, Abbott, Quidel, Siemens Healthcare, Danaher, Bio-Rad Laboratories, BioMerieux, ARKRAY, and Nova Biomedical. The market is dominated by North America, followed by Europe, Asia Pacific, the Middle East, Africa, and Australia. Regulatory and legal factors specific to this market include the implementation of strict regulations and guidelines by various regulatory bodies concerning the safety and efficacy of POC devices. Additionally, the increasing prevalence of chronic diseases such as diabetes and cardiovascular diseases has led to a rise in demand for POC devices.

Point of Care POC Devices Market Key Players

Mazor Key Player is listed in the Point of Care POC Devices

Roche

Abbott

Quidel

Siemens Healthcare

Danaher

Buy Now & Get Exclusive Discount on this:https://www.reportprime.com/enquiry/request-discount/10621

Point of Care POC Devices Market Segment Analysis

The Point of Care (POC) Devices market has witnessed significant growth in recent years, and it is expected to continue its growth trajectory in the future. The POC Devices market comprises diagnostic testing devices that can be used at the point where care is delivered, that is, at the patient’s bedside or in the immediate vicinity. The target market for POC devices includes hospitals, clinics, ambulatory care centers, nursing homes, and other healthcare facilities. The major factors driving revenue growth in this market include the increasing prevalence of chronic diseases, the rising demand for decentralized testing, and the need for rapid test results.

One of the latest trends in the POC Devices market is the integration of digital technologies. POC devices are being developed with advanced features such as connectivity, cloud computing, and artificial intelligence, which facilitate seamless data sharing and faster diagnostic decisions. The integration of digital technologies in POC devices is expected to enhance the accuracy and reliability of test results, while also improving workflow efficiency.

However, the POC Devices market also faces various challenges, such as the high costs associated with POC devices and the lack of adequate funding for their development and implementation. In addition, the lack of regulatory clarity and standardization creates uncertainty and hinders market growth. Manufacturers of POC devices also face intense competition from established players as well as new entrants.

The main findings of the report on POC Devices market indicate that the market is poised for significant growth in the coming years, driven primarily by the increasing demand for rapid testing and decentralized diagnostics. The market is also ripe for technological advancements, particularly in digital connectivity and artificial intelligence. To realize the market’s potential, manufacturers must focus on developing cost-effective and user-friendly devices while navigating regulatory hurdles.

The report recommends that manufacturers collaborate with healthcare institutions and providers to better understand their needs and preferences. Additionally, investment in research and development, as well as strategic partnerships with digital technology companies, can help accelerate innovation and market penetration. Ultimately, the successful adoption and implementation of POC devices will require the cooperation of stakeholders across the healthcare industry.

This report covers impact on COVID-19 and Russia-Ukraine wars in detail.

Purchase This Report:https://www.reportprime.com/checkout?id=10621&price=3590

Point of Care POC Devices (by Application)

Clinics

Hospitals

Laboratory

Others

Information is sourced from www.reportprime.com

[prachireport-prime1]

C-Reactive Protein Test（CRP）Market Size, Type, segmentation, growth and forecast 2023-2030

C-Reactive Protein Test（CRP）Market

The C-Reactive Protein Test（CRP） Market is expected to grow from USD 660.40 Million in 2022 to USD 993.00 Million by 2030, at a CAGR of 6.00% during the forecast period.

Get the Sample Report:https://www.reportprime.com/enquiry/sample-report/11049

C-Reactive Protein Test（CRP）Market Size

The C-Reactive Protein Test (CRP) is a diagnostic blood test that measures the level of the protein CRP in the body, which is produced by the liver in response to inflammation and infection. The global market for CRP tests is segmented by type, application, and region, including ELISA, Immunoturbidimetric, CLIA, hospitals, diagnostic laboratories, North America, Asia Pacific, Middle East, Africa, Australia, and Europe. Key market players include Beckman Coulter, Roche, Siemens Healthineers, Boditech, Wondfo, KANTO CHEMICAL, Kehua Group, Beijing Strong Biotechnologies, Getein Biotech, Randox Laboratories, Spinreact, BioSino, and Leadman Biochemistry. Regulatory and legal factors specific to market conditions include the FDA's approval of CRP tests for diagnosis and monitoring of bacterial infections and sepsis, as well as the increasing demand for point-of-care testing and the development of advanced CRP detection technologies.

C-Reactive Protein Test（CRP）Market Key Player

Beckman Coulter

Roche

Siemens Healthineers

Boditech

Wondfo

Buy Now & Get Exclusive Discount on this:https://www.reportprime.com/enquiry/request-discount/11049

C-Reactive Protein Test（CRP）Market Segment Analysis

The C-Reactive Protein Test (CRP) market is a rapidly growing sector as the demand for quick diagnosis and monitoring of infectious and inflammatory diseases has increased. The target market for CRP includes clinical diagnostic laboratories, hospitals, research institutes, and point of care (POC) testing facilities. This is due to the fact that CRP is one of the fastest and most reliable ways to diagnose inflammation within the body.

The COVID-19 pandemic has further contributed to the growth of the CRP market as the test is being used to monitor the severity of infection and predict potential adverse outcomes. Furthermore, the growing prevalence of chronic illnesses such as cardiovascular diseases, diabetes, and cancer is increasing the demand for CRP testing.

The latest trends in the CRP market include the adoption of automated systems for conducting testing and the integration of high sensitivity CRP (hs-CRP) testing in cardiovascular disease risk assessment. Additionally, the availability of CRP testing in POC settings has made it more accessible to patients, resulting in increased market growth.

However, challenges faced by the CRP market include the lack of standardization in testing methods, which can lead to inconsistent results, and the high cost of testing equipment and consumables. Furthermore, the high rate of false positives in CRP testing can lead to overdiagnosis and overtreatment, negatively impacting patient outcomes and increasing healthcare costs.

The main findings of the report indicate that the CRP market is expected to witness significant growth in the coming years, primarily due to the increasing prevalence of chronic diseases and the growing demand for point of care testing. The report recommends that market players focus on developing standardized testing methods and affordable testing equipment to address the challenges faced by the industry.

Overall, the CRP test market is poised for substantial growth, driven by increasing demand for quick diagnosis and monitoring of infectious and inflammatory diseases. While challenges exist in the form of standardization issues and equipment costs, continued research and investment may help overcome these obstacles and solidify the CRP testing industry's role in healthcare.

This report covers impact on COVID-19 and Russia-Ukraine wars in detail.

Purchase This Report:https://www.reportprime.com/checkout?id=11049&price=3590

Market Segmentation (by Application):

Hospitals

Diagnostic Laboratories

Others

Information is sourced from www.reportprime.com

[research--blog]

Africa IVD Market to be Worth $1.78 Billion by 2029 

According to a new market research report titled, ‘Africa In Vitro Diagnostics Market by Product & Services, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), and Customer Type - Forecast to 2029,’ published by Meticulous Research®, the Africa in vitro diagnostics market is expected to reach $1.78 billion by 2029, at a CAGR of 4.8% from 2022 to 2029.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5415

In vitro diagnostics (IVD) are tests performed on samples of blood or tissue taken from the human body to detect a wide range of diseases. These tests help monitor overall health to prevent and treat various diseases. IVD involves the use of various reagents, assays, and kits based on technologies such as immunoassay, whole blood glucose monitoring, molecular diagnostics, point of care, clinical chemistry, hematology, coagulation & hemostasis, critical care, and urinalysis.

High Prevalence of Infectious Diseases Driving the Growth of the Africa IVD Market

Diagnostic tests play a crucial role in the medical care of patients with infections. The demand for IVD kits used to diagnose infectious diseases is high in Africa due to the increasing awareness regarding emerging and re-emerging infectious diseases and the adoption of advanced molecular testing and lab-on-chip technology. The burden of diseases such as HIV, tuberculosis, malaria, viral hepatitis, and neglected tropical diseases (NTDs) is large in Africa. For example, according to WHO, in 2020, 25.6 million people were living with HIV in the African Region. The annual number of new HIV infections also increased in the Middle East and North Africa (source: UNAIDS data 2021).

In addition, there is a frequent outbreak of endemic diseases in Africa. For instance, Lassa fever is endemic in Nigeria and continues to be reported throughout the country. According to Nigeria Centre for Disease Control and Prevention (NCDC). In January 2022, 981 suspected and 211 confirmed cases of Lassa fever were reported in Nigeria. There were 40 deaths reported among confirmed cases, indicating a case fatality rate of 19%. Thus, the high burden of infectious diseases increases the demand for IVD tests in Africa.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5415

Africa IVD Market: Future Outlook

The Africa IVD market is segmented based on Product Category (Reagents, Assays, and Kits, Instruments, and Software & Services), Technology (Immunoassay, Whole Blood Glucose Monitoring, Point-of-Care Diagnostics, Clinical Chemistry, Molecular Diagnostics, Hematology, Coagulation & Hemostasis, Critical Care, Urinalysis, and Other IVD Technologies), Application (Infectious Diseases, Oncology, Diabetes, Endocrinology, Cardiology, and Other Applications), Diagnostic Approach (Laboratory Testing, Point-of-Care Testing, and OTC/Self Testing), and Customer Type (Hospital Labs, Private Labs, Home Care/Self Testing, Government, and Other Customer Types), and Geography (South Africa, Egypt, Nigeria, Kenya,  Algeria, Tanzania, Morocco, Tunisia, and the rest of Africa). The study also evaluates industry competitors and analyzes their market shares.

Based on product category, the reagents, assays, and kits segment is slated to register the fastest growth rate during the forecast period. In Africa, infectious diseases cause chronic illnesses, premature deaths, and loss of productivity, affecting the region's economic growth. Thus, the emerging threats of infectious diseases drive the demand for IVD in Africa. The frequent use of reagents for diagnosing diseases and the easy availability & accessibility of these tests are the major factors driving the growth of this segment.

Based on technology, the point of care segment is slated to register the fastest growth rate during the forecast period. The rising geriatric population, the growing prevalence of chronic diseases, and the rising incidence of infectious diseases are driving the growth of this segment. The increasing burden of chronic diseases and pathogen outbreaks has significantly increased the demand for PoC diagnostics in Africa. The increased need for early and accurate diagnosis, precise confirmation of clinical findings, and immediate & informed decision-making on treating diseases contributes to the growth of the PoC segment.

Based on application, the oncology segment is slated to register the fastest growth rate during the forecast period. Cancer involves a complex set of genetic alternations and subsequent changes in gene expression, leading to the uncontrolled proliferation of cells. In cancer diagnostics, early diagnosis and knowing the exact nature of the tumor are of prime importance. Early cancer detection and access to effective anti-cancer treatment can result in higher rates of survival and a better quality of life. According to GLOBOCAN 2020, 1.1 million new cases and 711,429 deaths were recorded in Africa. The growing demand for personalized medicines in cancer therapy, the increasing prevalence of cancer, and the rising demand for rapid cancer diagnosis tests drive the growth of the IVD market for oncology applications.

Based on diagnostic approach, the OTC/self-testing segment is slated to register the fastest growth rate during the forecast period. In Africa, over-the-counter (OTC)/self-testing is promoted for diseases, such as HIV and COVID-19, due to the high prevalence of infectious diseases. Self-testing reduces the burden on healthcare workers and the system. The OTC/self-testing kits are diagnostic tests that can be purchased from any pharmacy store and used by the patient. These tests can give rapid results and can be taken from anywhere.

Quick Buy – Africa IVD Market Research Report: https://www.meticulousresearch.com/Checkout/47708335

Based on customer type, the home care/self-testing segment is slated to register the fastest growth rate during the forecast period. The growth of this segment is attributed to the increasing need to monitor and manage chronic diseases, the growing awareness about home healthcare testing products, and the reduced waiting time and healthcare costs offered by self-testing kits.

This research report analyzes the market across major African countries and provides a comprehensive analysis of South Africa, Algeria, Nigeria, Kenya, Morocco, Tunisia, Tanzania, Egypt, and the rest of Africa.

Key companies operating in the Africa IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/africa-ivd-market-5415

Scope of the Report

Africa IVD Market, by Product Category

Reagents, Assays, and Kits

Instruments

Software & Services

Africa IVD Market, by Technology

Immunoassay

Whole Blood Glucose Monitoring

Point-of-Care Diagnostics

Clinical Chemistry

Molecular Diagnostics

Hematology

Coagulation & Hemostasis

Critical Care

Urinalysis

Other IVD Technologies

Note: Other technologies include microscopy, hybridization, and loop-mediated amplification.

Africa IVD Market, by Application

Infectious Diseases

Oncology

Diabetes

Endocrinology

Cardiology

Other Applications

Note: Other applications include nephrology, toxicology, gastroenterology, neonatal, genetic, and neurological disorders.

Africa IVD Market, by Diagnostic Approach

Laboratory Testing

Point-of-Care Testing

OTC/Self-testing

Africa IVD Market, by Customer Type

Hospital Labs

Private Labs

Home Care/Self Testing

Government

Other Customer Types

Note: Other customer types include long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories.

Africa IVD Market, by Country

South Africa

Egypt

Nigeria

Kenya

Algeria

Tanzania

Morocco

Tunisia

Rest of Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5415

In Vitro Diagnostic (IVD) Reagents Market - https://www.meticulousresearch.com/product/in-vitro-diagnostic-reagents-market-5110

[worldwideanalysis]

Biosensors Market Will be Dominated by North America

The biosensors market will reach USD 49.3 billion by 2030, powering at a rate of 7.8% in the years to come.

This has a lot to do with the introduction of nanotechnology-based devices and the increasing acceptance of sensors for the detection of blood-sugar in diabetic patients.

Moreover, the supplementing requirement for home-based point-of-care testing, as well as the increase in the number of product approvals by controlling authorities, is helping the growth of the industry.

Embedded devices dominated the industry in the past. This was because of their growing use in home-based diagnostics, research labs, and POC testing.

By the way, the high acceptance of IoT in home healthcare settings for instantaneous tracking, monitoring, and alerting is increasing the growth of the category.

Moreover, in the past, there has been an surge in the acceptance of embedded solutions combined with IoT in healthcare settings for tackling the inaccessibility of healthcare specialists in remote areas.

These solutions contribute in the identification of a number of disorders and manage dissimilar diagnostic tests, for allowing doctors to deliver dependable and specific treatments remotely.

The requirement for wearable biosensors will have the fastest growth , with around 8%, in the years to come, mainly credited to their aptitude to bring the notion of medical diagnostics to the homes of patients, therefore saving both time, and medical costs.

These sensors, combined with a physiochemical detector, analyzing a biological element, support in the detection of numerous chemical substances accountable for the progression of the disease.

Furthermore, wearable analytical devices support in the early discovery of hostile health events and the hospitalization prevention.

The electrochemical category dominated the industry, driven by the increase in the usage of this technology for biochemical and biological analyses. This offers high steadiness, an extensive linear response range, and no discovery limits, thus resultant in high usage in the healthcare domain.

Also, this technology is preferred by users because of its cost-effectiveness, robust nature, user-friendliness, high compatibility with new microfabrication equipment, and lower consumption of power.

North America dominated the biosensors market, with above 40% share, powered by an increasing aging population, growing health awareness, tech expansions in numerous home-use medical devices, and apt insurance coverage.

The growing occurrence of lifestyle-associated, and chronic diseases is also powering the growth of the industry. This region makes use of this tech over other regions owing to the advancements technology and an extensive uses across industries.

Further, because of the high healthcare spending, these systems are widely used to precisely, dependably, and rapidly detection and prevention of ailments early.

Because of the introduction of nanotechnology-based devices, the demand for biosensors will grow considerably in the years to come.

[blueweave]

Vietnam in vitro diagnostics market size at USD 1,391.25 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects Vietnam in vitro diagnostics market size to grow at a significant CAGR of 4.65% reaching a value of USD 1,900.46 million by 2029. Major growth factors of Vietnam in vitro diagnostics market include increasing need for accurate and efficient diagnostic tests, increasing demand for in-vitro serological tests, growing need for early diagnosis to provide the finest patient care and effective treatment, as well as determining the true cause of the ailment. The rising prevalence of chronic diseases, such as cardiovascular disease, renal disease, and chronic respiratory disease, is fueling the expansion of the Vietnam in vitro diagnostics market during the period in analysis. Rising instances of neurological illnesses will also drive the market expansion. The surging demand for serological tests due to an increase in pregnancy cases, as well as an increase in diabetes cases, is raising demand for improved kits for in-home blood sugar analysis, assisting in the expansion of Vietnam in vitro diagnostics market in the coming years. The growing geriatric population and increasing number of elderly people susceptible to chronic and infectious diseases has boosted the demand for frequent checks and increased serological testing, helping the growth of the Vietnam in vitro diagnostics market during the forecast period.

Vietnam In Vitro Diagnostics Market – Overview

In vitro diagnostics (IVDs) are the methods and tests that use serological examination of bodily fluids to uncover underlying causes of diseases and comprehend biological functions. The tests are also frequently used to monitor a person's overall health in order to maintain the patient's health and prevent future ailments. Some of the most common forms of IVD tests are blood testing, urine tests, sperm analysis, vaginal swab analysis, and others. These tests are also used to analyze pregnancy, blood glucose levels, illness, and organ function. IVD point-of-care (PoC) testing is needed to speed up patient management and improve access to services. This testing involves directly measuring an analyte in a patient's sample at the hospital without sending it to a laboratory. This approach can offer several benefits, including faster results and robust interventions. The development of condition-specific markers is expected to have a significant impact on the market economy.

Sample Request @https://www.blueweaveconsulting.com/report/vietnam-in-vitro-diagnostics-market/report-sample

[shital1998]

Point Of Care Diagnostics Market - Global Opportunity Analysis and Industry Forecast (2022-2029)

Meticulous Research®—a leading global market research company, published a research report titled, ‘Point-of-care Diagnostics Market by Application (Influenza, Pneumonia, COVID-19, TB, HAI, Hepatitis, HIV, Glucose, Coagulation, Hematology, Cancer, Cardiac), Platform, Purchase Mode (Prescription, OTC), End User (Home Care, Hospital)—Global Forecast to 2029.’

According to this latest publication from Meticulous Research®, the point-of-care diagnostics market is expected to reach $82.74 billion by 2029, at a CAGR of 7.4%. The growth of this market is driven by the increasing prevalence of chronic diseases and the rapidly growing demand for cost-effective and innovative POC diagnostic products.

Point-of-care Diagnostics Market: Future Outlook

The point-of-care diagnostics market is segmented based on Application (Infectious Disease Testing {Respiratory Infections Testing [Influenza, Tuberculosis, Pneumonia, Other Respiratory Infections], Healthcare-Associated Infection (HAI) Testing, Parasitic Infections, Gastrointestinal infections [Salmonellosis, E. coli Infections, Other GI infections], Blood-borne Infections Testing [Hepatitis, HIV, Other Blood-borne infections], Other Infectious Diseases testing}, Blood Glucose Monitoring {Test Strips, Glucometers, Lancets, Hemoglobin A1c Test Kits}, Cardiac Marker/Cardiac Metabolism, COVID-19 Testing, Coagulation Test {Prothrombin Time (PT/INR) Test, Activated Clotting Time (ACT/aPTT) Test, Other Tests}, Pregnancy and Fertility Testing {Pregnancy Test, Fertility Test}, Fecal Occult Testing, Hematology, Tumor/Cancer Markers Testing, Drugs of Abuse Test, Urinalysis, Cholesterol/lipid profile Testing, Other PoC Tests), Platform (Lateral Flow Assays, Molecular Diagnostics, Other Platforms), Mode of Purchase (Prescription-based Tests, Over-the-counter Tests), End User (Home Care/Self Testing, Hospitals, Physician offices & Ambulatory Care Settings, Diagnostics Labs, Other End Users), and Geography. The study also evaluates industry competitors and analyzes the market at the global and regional levels.

Download Sample Report Here:https://www.meticulousresearch.com/download-sample-report/cp_id=4871

Scope of the Report:

 Point-of-care Diagnostics Market, by Application

·         Infectious Diseases Testing

o    Respiratory Infections Testing

§  Influenza

§  Tuberculosis (TB)

§  Pneumonia

§  Other Respiratory Infections

o    Healthcare-Associated Infection (HAI) Testing

o    Parasitic Infections

o    Gastrointestinal (GI) Infections

§  Salmonellosis

§  E. coli Infections

§  Other GI Infections

o    Blood-borne Infections Testing

§  Hepatitis

§  HIV

§  Other Blood-borne Infections

o    Other Infectious Disease Testing

·         Blood Glucose Monitoring

o    Test Strips

o    Glucometers

o    Lancets

o    Hemoglobin A1c Test Kits

·         Cardiac Marker / Cardiac Metabolism Testing

·         COVID-19 Testing

·         Coagulation Tests

o    Prothrombin Time (PT/INR) Tests

o    Activated Clotting Time (ACT/aPTT) Tests

o    Other Coagulation Tests

·         Pregnancy and Fertility Testing

o    Pregnancy Tests

o    Fertility Tests

·         Fecal Occult Testing

·         Hematology

·         Tumor/Cancer Markers Testing

·         Drugs of Abuse Test

·         Urinalysis

·         Cholesterol/Lipid Profile Testing

·         Other PoC Tests

Point-of-care Diagnostics Market, by Platform

·         Lateral Flow Assays

·         Molecular Diagnostics

·         Other Platforms

Point-of-care Market, by Mode of Purchase

·         Prescription-based Tests

·         Over-the-Counter (OTC) Tests

Point-of-care Market, by End User

·         Home Care/Self Testing

·         Hospitals

·         Physician offices & Ambulatory Care Settings

·         Diagnostics Labs

·         Other End Users

Point-of-care Diagnostics Market, by Geography

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    U.K.

o    France

o    Italy

o    Spain

o    Rest of Europe (RoE)

·         Asia-Pacific (APAC)

o    China

o    Japan

o    India

o    Rest of APAC (RoAPAC)

·         Latin America (LATAM)

o    Brazil

o    Mexico

o    Rest of Latin America (RoLATAM)

·         Middle East & Africa

Speak with Our Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=4871

Based on application, in 2022, the infectious diseases testing segment is expected to account for the largest share of the point-of-care diagnostics market. The large market share of this segment is attributed to the COVID-19 outbreak, the high prevalence of other infectious diseases, and the increase in accessibility to rapid disease diagnosis.

Based on platform, the point-of-care diagnostics market is segmented into lateral flow assays, molecular diagnostics, and other platforms. In 2022, the lateral flow assays segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the affordability, accessibility, ease of use, and clinical utility of lateral flow assays in POC applications.

Based on mode of purchase, in 2022, the prescription-based tests segment is expected to account for the largest share of the point-of-care diagnostics market. Prescription-based point-of-care diagnostics products are used for critical care, infectious disease, cardiac markers, coagulation, hematology and other health conditions. The increase in prescriptions for these devices has contributed to the large market share of this segment.

Based on end user, in 2022, the hospitals segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the high demand for point-of-care diagnostics in emergency departments of hospitals. Rapid diagnosis has become crucial in emergency departments to reduce overcrowding due to increased primary care referrals. Connecting point-of-care devices to hospital information systems linked with electronic medical records offers several benefits, including faster access to clinical information, the ability to communicate test results more quickly, and eliminating challenges associated with reading errors. Point-of-care diagnostics products help hospitals improve overall efficiency by enabling quick monitoring, prognosis, and operational decision-making, driving their adoption in hospital settings.

This research report analyzes major geographies and provides a comprehensive analysis of the market in North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and Middle East & Africa. In 2022, North America is expected to account for the largest share of the point-of-care diagnostics market. North America’s major market share is attributed to the strong penetration of point-of-care diagnostics products, advanced healthcare infrastructure, high healthcare expenditure, and the presence of key market players in the U.S. and Canada.

Access full Report Description, TOC, Table of Figure, Chart, etc: https://www.meticulousresearch.com/product/point-of-care-diagnostics-market-4871

Key Players The key players operating in the point-of-care diagnostics market are Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Quidel Corporation (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), CHEMBIO DIAGNOSTICS, INC. (U.S.), EKF Diagnostics (U.K.), Trinity Biotech plc (Ireland), Werfen, S.A. (Spain), Nova Biomedical (U.S.), Sekisui Diagnostics (U.S.), Thermo Fisher Scientific (U.S.), and bioMérieux S.A. (France). Key questions answered in the report:

·  Which are the high-growth market segments in terms of application, platform, mode of purchase, end user, and region/country?

·  What was the historical market size for point-of-care diagnostics across the globe?

·  What are the market forecasts and estimates for the period 2022–2029?

·  What are the major drivers, restraints, opportunities, challenges, and trends in the point-of-care diagnostics market?

·  Who are the major players in the point-of-care diagnostics market?

·  How is the competitive landscape, and who are the market leaders in the point-of-care diagnostics market?

·  What are the recent developments in the point-of-care diagnostics market?

·  What are the different strategies adopted by the major players in the point-of-care diagnostics market?

·  What are the geographical trends and high growth regions/countries?

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

[ameymeti2001]

Rapid Diagnostics Market Worth $26.4 billion by 2029

Rapid Diagnostics Market Worth $26.4 billion by 2029

According to this latest publication from Meticulous Research®, the global rapid diagnostics market is expected to grow at a CAGR of 1.4% from 2022–2029 to reach $26.40 billion by 2029. The growth in the rapid diagnostics market is mainly attributed to the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the increasing need for rapid decision making in emergency departments, and emerging technological innovations. However, the occurrence of variances in test results is expected to hinder the growth of this market.

The global rapid diagnostics market is segmented based on Product (Kits and Test Readers/Analyzers), Platform (Immunoassays, Molecular Detection, and Other Platforms), Application (Blood Glucose Testing, Cardiac Metabolism Testing, Infectious Diseases Testing, Coagulation Testing, Pregnancy & Fertility Testing, Fecal Occult Testing, Hematology Testing, Tumor/Cancer Markers Testing, Drugs Of Abuse Testing, Urinalysis, and Cholesterol Testing), End User (Hospitals & Clinics, Diagnostic Laboratories, Home Care/Self Testing, and Other End Users) and Geography. The study also evaluates industry competitors and analyzes their market shares at the global and regional levels.

Based on product, the kits segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is attributed to the rising adoption and repetitive kits usage. In addition, the growing portfolio of disease-specific kits for the early diagnosis of chronic diseases and the increasing technological advancements are other factors supporting the growth of this segment.

Based on platform, the immunoassays segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is attributed to the capability of immunoassay kits to provide fast and accurate results with high sensitivity in point-of-care diagnostics. Countries worldwide require rapid and accurate SARS-CoV-19 testing kits to tackle the COVID-19 pandemic. Thus, companies have started developing immunoassay kits that provide results with higher sensitivity, accuracy, and speed. For instance, in May 2021, Stream Bio (U.K.) and Chelsea Technologies (U.K.) formed a joint venture, Brightline Diagnostics (DX), and created a unique platform known as Claritas that couples fluorescent lateral flow test with a highly sensitive handheld reader, delivering significant advantages over existing assays.

Based on application, the infectious disease testing segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is mainly attributed to the rising prevalence of infectious diseases and the growing demand for affordable infectious disease testing in emerging markets. For instance, in the U.S., the number of estimated new hepatitis A virus (HAV) infections increased by nearly three folds in 2017 compared to 2014.

In 2019, the number of estimated new hepatitis A virus (HAV) infections rose by approximately 51% compared to the previous year due to the significant increase in the homeless population and the population involved in drug abuse. Similarly, there is a large prevalence of infectious diseases in China. According to China’s Centre for Disease Control (CCDC), the country accounts for 3% of new HIV infections every year and reported over 850,000 people living with HIV.

Based on end user, the hospitals & clinics segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is mainly attributed to the increasing demand for point-of-care diagnostics and the rising healthcare expenditure worldwide. For instance, according to Invest India (National Investment Promotion and Facilitation Agency), the hospital and healthcare industry in India forecasts tremendous growth due to the significant increase in coverage and healthcare spending. In addition, the government announced plans to spend over $200 billion on medical infrastructure by 2024, which will support the establishment of new hospitals & clinics.

𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 @https://www.meticulousresearch.com/request-sample-report/cp_id=5240?utm_source=product&utm_medium=Social&utm_campaign=Product&utm_content=09-01-2023

Scope of the Report

Rapid Diagnostics Market, by Product

Kits

OTC Kits

Professional Kits

Equipment

Rapid Diagnostics Market, by Platform

Immunoassays

Lateral Flow Assays

Serological Assays

Other Immunoassays

Molecular Detection

Other Platforms

(Note – Other Immunoassays includes flow through immunoassays and agglutination assays; and Other platforms mainly include coagulation tests, glucose monitoring systems, dipsticks, and other rapid diagnostic platforms)

Rapid Diagnostics Market, by Application

Infectious Diseases Testing

COVID-19 Testing

Healthcare-associated Infections (HAI) Testing

Hepatitis Testing

Hepatitis B

Hepatitis C

Tropical Diseases Testing

HIV Testing

Respiratory Diseases Testing (other than Influenza and COVID-19)

Influenza Testing

Sexually Transmitted Diseases (STD) Testing

Other Infectious Diseases Testing

Pregnancy & Fertility Testing

Cardiac Metabolism Testing

Cholesterol Testing

Tumor/Cancer Markers Testing

Blood Glucose Testing

Urinalysis

Hematology Testing

Other Tests

(Note – Other tests include drugs of abuse, fecal occult, and coagulation tests; Other infectious disease testing include meningitis, norovirus (“stomach flu”), hand, foot and mouth disease (HFMD), and pertussis)

Rapid Diagnostics Market, by End User

Hospitals & Clinics

Diagnostic Laboratories

Home Care/Self Testing

Other End Users

Global Rapid Diagnostics Market, by Geography

North America

U.S.

Canada

Europe

Germany

U.K.

France

Italy

Spain

Rest of Europe (RoE)

Asia-Pacific (APAC)

China

Japan

India

Rest of APAC (RoAPAC)

Latin America

Middle East & Africa

𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑭𝒓𝒆𝒆 𝑺𝒂𝒎𝒑𝒍𝒆 @https://www.meticulousresearch.com/download-sample-report/cp_id=5240?utm_source=product&utm_medium=Social&utm_campaign=Product&utm_content=09-01-2023

[healthcare-domain]

Sepsis Diagnostics Market Growth Drivers & Opportunities | MarketsandMarkets

The demand for sepsis diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for sepsis diagnostic research activities, the growing burden of infectious diseases, the rising number of sepsis incidences, and growing government initiatives for creating sepsis awareness.

Sepsis is a very difficult condition to diagnose and the risk of mortality increases by 7.6% with a delay of even 1 minute in antibiotic administration in septic shock patients with hypertension. Thus, increasing the need for the rapid diagnosis of sepsis to reduce the delay of antibiotic therapy among patients with sepsis. Many sepsis diagnostic manufacturers are expanding their product offering in point of care technology rapidly detecting the sepsis, reducing the overall turnaround time of diagnosis.

The BACTEC Plus, BacT/Alert, and BACTEC FX blood culturing instruments manufactured by BD Company (US) is an automated microbial detection system offering a rapid diagnosis of sepsis in the turnaround time of three hours.

According to the new market research report "Sepsis Diagnostics Market by Technology (Microbiology, PCR, Sequencing, Biomarkers), Product (Reagents, Assay, Instruments, Software), Test Type (Lab, POC), Pathogen (Bacterial, Viral, Fungal), End User (Hospital, Pathology Lab) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is expected to reach USD 771 million by 2026 from USD 503 million in 2021, at a CAGR of 8.9% from 2021 to 2026.

Browse in-depth TOC on "Sepsis Diagnostics Market" 201 – Tables 47 – Figures 236 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=92673155

The demand for sepsis diagnostic products is expected to grow mainly due to factors such as the rising prevalence of sepsis across the globe. Factors such as the increasing geriatric population, a growing number of surgical procedures, a high incidence of hospital-acquired infections, and the commercialization and availability of a wide variety of approved sepsis diagnostic devices are expected to drive market growth.

The COVID-19 pandemic had a positive effect on the sales of diagnostics products for sepsis. The global spread of covid-19 and the emerging cases of sepsis among covid-19 patients are likely to increase the demand for rapid diagnosis, accelerating the utilization of instruments, reagents, assay kits for detection of sepsis. Lockdowns resulting from the pandemic caused people to delay undergoing health checkups, affecting the number of tests performed and reagent sales.

The shortage of skilled professionals is a major concern worldwide; only 50% of patients with severe sepsis transported by the EMS system have a paramedic. The lack of trained paramedics affects each phase of patient caremdash;sepsis awareness, screening patients for the presence of sepsis, and making an appropriate.

The current COVID-19 pandemic has highlighted the risk faced by older adults, who are more susceptible to complications, including acute respiratory distress syndrome, usually due to pneumonia, which increases the risk of developing sepsis. Thus, increasing the need for early diagnosis of sepsis among patients with covid-19 infections.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=92673155

Based on technology, the biomarkers segment is expected to register the highest growth rate during the forecast period

Based on technology, the global sepsis diagnostics market is segmented into microbiology, molecular diagnostics, immunoassay, flow cytometry, microfluidics, and biomarkers. The biomarkers segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to various advantages offered by this technique in the diagnosis of sepsis and the growing need for early disease diagnosis.

North America accounted for the largest share of the sepsis diagnostics market

Geographically, the sepsis diagnostic market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to account for the largest share of the market. This can be attributed to the growing prevalence of sepsis, increasing incidence of hospital-acquired infections, fast adoption of high-end sepsis diagnostics devices, and rising government support for sepsis-related research.

[marketinsight12]

Point of Care Diagnostics Market Size-Share, Growth Factors, Forecast 2022-2028

Global Point of Care Diagnostics Market was valued at USD 30.30 billion in 2021 and is expected to reach USD 53.98 billion by the year 2028, at a CAGR of 8.6%.

Point-of-care testing (POCT) is critical for detecting analytes close to the patient, allowing for better disease diagnosis, monitoring, and management. It allows for quick medical decisions because diseases can be diagnosed at an early stage, resulting in better health outcomes for patients by allowing for the early start of treatment. POC testing was first used in 1962 with the development of a method for rapid analysis of blood glucose, and soon after, in 1977, rapid pregnancy tests were developed, ushering in a trend for personalized diagnostics. POC diagnostic devices for monitoring glucose, ECG, blood pressure, and other parameters have greatly aided clinical and personalized healthcare.

 Read More:

The Global Point of Care Diagnostics Market study contains information on the global industry, as well as user data and numbers. The Global Market is examined in depth in this research report, including raw material suppliers, industry chain structures, and manufacturing. The Point of Care Diagnostics Market Sales market investigates the market's most important segments. This insightful analysis includes historical data as well as a predicted timeframe. This report examines the whole value chain, as well as downstream and upstream fundamentals.